Trammell Crow to build 500K-square-foot life sciences complex in Frederick

5 Questions With Adaptive Phage Therapeutics American Gene Technologies antigen-specific T cells Astek Diagnostics AstraZeneca ATCC atccbiohealth-capital-region BioBuzz Awards BioHealth Capital Region biohealth-capital-regioncovid19 biohealth-capital-regioncovid19novavax biohealth-capital-regionfunding biohealth-capital-regionphiladelphia biohealth-capital-regionregenxbio biohealth-capital-regiontedco BioNTech bioprocessing BioTrain Capital Projects CAR-T Caring Cross CASI Pharmaceuticals Castle Creek Biosciences Center for Breakthrough Medicines Charles River Laboratories Childrens Hospital of Philadelphia Childrens National Hospital clinical-stage biotechnology Coronavirus COVID19 Delfi Diagnostics diversity Emergent BioSolutions FITCI Gain Therapeutics Gene Therapy George Mason University Gilead Sciences HIV I-Mab Intellectual Property JLABS Johns Hopkins University KAPAL Kite Pharma Maryland Maryland Department of Commerce Maryland Stem Cell Research Fund Maryland Tech Council Maxcyte Maxim Biomedical MaximBio Mcbee Moore and Vanik Medimmune Merck NeoImmuneTech NexImmune Novavax People On The Move PQE Group Press Release Qiagen REGENXBIO regionlab Sirnaomics spacepress Technology TEDCO Tonix Pharmaceuticals United States Pharmacopeia United Therapeutics University of Maryland Baltimore Vaccine Vaccines Viela Bio Vigene Biosciences VLP Therapeutics Women In Bio Workforce Genetics